Search

Your search keyword '"Rancati, Tiziana"' showing total 197 results

Search Constraints

Start Over You searched for: Author "Rancati, Tiziana" Remove constraint Author: "Rancati, Tiziana" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
197 results on '"Rancati, Tiziana"'

Search Results

1. A Computational Model of the Tumor Microenvironment Applied to Fractionated Radiotherapy

2. Optimising inter-patient image registration for image-based data mining in breast radiotherapy

3. Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients

5. Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

8. Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer

13. Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation

14. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

15. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

18. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

19. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients

21. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

22. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

23. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

24. Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis.

25. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

27. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

28. Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT

30. Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review

31. 1984: Cox-based prediction model of grade 5 bleeding after SBRT of ultra-centrally located lung tumors.

32. Knowledge-Based Plan Prediction Modelling of Whole Breast Irradiation: An International Inter-Consortium Experience

33. Optimising Inter-Patient Image Registration for Image-Based Data Mining in Breast Radiotherapy

34. Fat Necrosis after One-Week Partial Breast Irradidation or Standard of Care: A Case-Control Study

35. Comparing Performances of Predictive Models of Toxicity after Radiotherapy for Breast Cancer Using Different Machine Learning Approaches.

36. Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes

38. 2937: Dose deposition in sub-regions of breast relates to acute and persistent pain after radiotherapy

39. 2516: NTCP model of acute toxicity after whole breast irradiation: training and extended validation

41. 2437: Clinical predictors of late lymphopenia in PCa patients undergoing radical or post-operative WPRT

43. 2391: Longitudinal assessment of the impact of pelvic nodal radiotherapy on lymphopenia in PCa treatment

45. 2287: Bone marrow dose-volume predictors of late lymphopenia after pelvic lymph node irradiation for PCa

50. 1568: Toward multi-institutional Knowledge-Based benchmark for right and left whole breast irradiation

Catalog

Books, media, physical & digital resources